染色內視鏡試劑市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品、應用、最終用戶、地區和競爭格局分類），2021-2031年

全球染色內視鏡藥物市場預計將從 2025 年的 2.2 億美元成長到 2031 年的 3.2 億美元，複合年成長率為 6.44%。

這些試劑由特殊的生化染色劑組成，在內鏡檢查過程中局部塗抹，可突出顯示黏膜形態，並有助於檢測胃腸道病變。市場成長的主要促進因素是全球消化器官系統惡性腫瘤發生率的上升趨勢，以及早期診斷準確性對改善患者預後的重要性日益凸顯。此外，各國廣泛開展癌症篩檢計畫以及老齡化人口不斷成長（胃腸道疾病高風險族群）也大大推動了對這些診斷輔助工具的需求成長。

市場面臨的主要障礙是虛擬染色內視鏡系統的日益普及。該系統無需耗時的物理染色步驟即可實現數位化組織增強。這種數位技術的操作優勢對傳統化學試劑的常規應用構成了競爭威脅。然而，由於目標疾病的高發生率，有效檢測仍具有臨床意義。例如，美國癌症協會估計，到2025年，美國將有約154,270人被診斷出罹患大腸癌，凸顯了對精準診斷工具的持續需求。

市場促進因素

全球胃腸道疾病發生率的不斷上升是染色內視鏡造影劑市場的主要驅動力，也因此產生了對卓越視覺化能力的迫切臨床需求。隨著胃腸道惡性腫瘤發生率的不斷攀升，內視鏡醫師越來越依賴特殊染色劑來識別標準影像可能遺漏的細微病變，這對於檢測大腸直腸癌病例中的發育不良至關重要。根據國際癌症研究機構（IARC）於2025年2月發布的關於結直腸癌宣傳月的聲明，全球每年約有190萬例新發結直腸癌病例，這確保了用於高清監測檢測和靶向切片檢查的造影劑需求將持續成長。

同時，人們對結直腸癌篩檢計畫的日益關注顯著增加了全球範圍內的診斷程序數量，從而推動了市場擴張。公共衛生宣傳活動和國家計劃有效地促進了預防性篩檢的參與，使得需要使用染色內視鏡輔助檢查的患者群體不斷擴大。根據美國國家大腸直腸癌圓桌會議2025年8月報告，2024年美國醫療機構的大腸癌篩檢數量增加至3,617,246例。檢測量的成長也反映在產業的財務表現中。例如，Olympus Corporation2025年5月報告稱，其內視鏡解決方案部門的營收上年度增8.4%，凸顯了診斷內視鏡領域的穩健成長。

市場挑戰

全球染色內視鏡市場成長的關鍵障礙之一是虛擬染色內視鏡系統與標準臨床工作流程的快速整合。與傳統的手動應用生化染色劑來觀察黏膜細節的方法不同，數位化替代方案可透過整合的內視鏡軟體實現組織即時顯色。這種操作效率的提升省去了物理染色劑的準備和清理時間，顯著簡化了醫療團隊的工作流程。因此，醫療機構對耗材染色劑的依賴性日益降低，並開始採用這些內建的數位化功能，這直接影響了化學品製造商的經常性收入。

考慮到全球胃腸道疾病負擔之重，所需的檢測數量龐大，這種市場佔有率的下降尤其顯著。對篩檢的巨大需求正擴大透過數位化解決方案而非化學輔助手段來滿足。例如，全球癌症觀察站報告稱，到2024年，胃癌約佔全球新增癌症病例的4.9%，這反映了該診斷領域的規模之大。隨著醫療專業人員轉向數位化視覺化來應對這一患者負擔，物理染色內視鏡試劑的常規使用正在持續下降。

市場趨勢

口服給藥系統的開發正顯著地推動市場發展，為傳統的染料噴灑方法提供了標準化、以患者為中心的替代方案。這一趨勢的核心是緩釋亞甲基藍片劑的商業性化應用，該片劑旨在特異性在大腸內崩壞，從而有效消除了導管給藥方法通用的粘膜覆蓋不均和檢測延遲等問題。這些藥物創新的商業性成功體現在領先製造商強勁的財務表現上。例如，Cosmo Pharmaceuticals在2025年7月公佈的上半年經常性收入為4,190萬歐元，這主要得益於其專有的胃腸道產品（包括先進的給藥系統）的日益普及。

同時，人工智慧輔助診斷平台與染色內視鏡技術的融合正在建立新的臨床標準。在該技術中，化學試劑作為電腦輔助檢測（CADe）系統中重要的造影增強劑。這種協同方法利用生化染料突出細微粘膜異常的能力，並透過深度學習演算法進行處理，從而提高病變檢出率並最大限度地減少操作者差異。技術的融合正在推動診斷行業的顯著成長；FUJIFILM Holdings株式會社於2025年5月宣布，其醫療保健部門的收入將達到1.226兆日元，這表明市場對支持這些混合診斷工作流程的先進成像生態系統有著強勁的需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章全球色素內視鏡藥物市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 副產物（吸收性造影、造影、反應性造影）
  • 透過用途（大腸/直腸、食道、胃）
  • 按最終使用者（門診手術中心、診斷中心、醫院/專科診所、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

6. 北美染色內視鏡藥物市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7.歐洲色素內視鏡檢查劑市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8.亞太地區色素內視鏡藥物市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲染色內視鏡試劑市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

10.南美色素內視鏡製劑市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球染色內視鏡試劑市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Merck & Co., Inc.
• Enzo Life Sciences Inc
• Thermo Fisher Scientific Inc
• Cosmo Pharmaceuticals SA
• Loba Chemie Pvt Ltd
• Provepharm SAS
• Sisco Research Laboratories Pvt Ltd
• Medtronic PLC
• Boston Scientific Corp

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Chromoendoscopy Agents Market is projected to expand from USD 0.22 Billion in 2025 to USD 0.32 Billion by 2031, registering a CAGR of 6.44%. These agents consist of specialized biochemical dyes and stains applied locally during endoscopic examinations to highlight mucosal topography and facilitate the detection of gastrointestinal lesions. Market growth is primarily driven by the increasing global prevalence of gastrointestinal malignancies and a heightened focus on early diagnostic accuracy to enhance patient prognosis. Additionally, the proliferation of national cancer screening initiatives, alongside an aging population prone to digestive conditions, provides a strong foundation for the rising consumption of these diagnostic aids.

A major obstacle facing the market is the rising utilization of virtual chromoendoscopy systems, which offer digital tissue enhancement without the time-intensive process of applying physical dyes. This operational advantage of digital technologies presents a competitive threat to the standard use of traditional chemical agents. However, the essential clinical requirement for effective detection persists due to the high incidence of target diseases. For instance, the American Cancer Society estimated in 2025 that approximately 154,270 individuals in the United States would be diagnosed with colorectal cancer, underscoring the continued need for accurate diagnostic tools.

Market Driver

The increasing global incidence of gastrointestinal disorders serves as a primary propellant for the Chromoendoscopy Agents Market, creating an urgent clinical demand for superior visualization capabilities. With the prevalence of gastrointestinal malignancies on the rise, endoscopists are depending more frequently on specialized dyes to identify subtle lesions that standard imaging might miss, a practice essential for detecting dysplasia in colorectal cancer cases. According to a February 2025 statement by the International Agency for Research on Cancer (IARC) regarding Colorectal Cancer Awareness Month, roughly 1.9 million new cases of colorectal cancer are diagnosed annually worldwide, ensuring a sustained and growing need for contrast agents used in high-definition surveillance and targeted biopsies.

Concurrently, heightened awareness regarding colorectal cancer screening programs is stimulating market expansion by significantly boosting the number of diagnostic procedures conducted globally. Public health campaigns and national initiatives are effectively driving participation in preventative screenings, resulting in a larger patient pool requiring endoscopic assessment with chromoendoscopy adjuncts. As reported by the National Colorectal Cancer Roundtable in August 2025, the number of patients screened for colorectal cancer in U.S. health centers rose to 3,617,246 in 2024. This increase in procedural volume is reflected in industry financial results; for example, Olympus Corporation reported in May 2025 that revenue for its Endoscopic Solutions segment grew by 8.4% over the prior fiscal year, highlighting robust growth in the diagnostic endoscopy sector.

Market Challenge

The principal hindrance to the growth of the Global Chromoendoscopy Agents Market is the swift integration of virtual chromoendoscopy systems into standard clinical workflows. In contrast to traditional methods that require the manual application of biochemical stains to reveal mucosal details, digital alternatives permit immediate tissue enhancement via integrated endoscopic software. This operational efficiency eliminates the preparation and cleaning time linked to physical dyes, significantly streamlining the workflow for medical teams. As a result, healthcare facilities are increasingly diminishing their dependence on consumable staining agents in favor of these built-in digital capabilities, which directly impacts the recurring revenue of chemical agent manufacturers.

This decline in market share is particularly significant given the substantial procedural volume necessary to manage the global burden of digestive diseases. The immense demand for screening is increasingly being addressed through digital solutions rather than chemical adjuncts. To highlight the scale of this diagnostic sector, the Global Cancer Observatory reported that stomach cancer accounted for approximately 4.9% of all new cancer cases globally in 2024. As medical professionals shift toward digital visualization to handle this patient load, the routine utilization of physical chromoendoscopy agents is experiencing a sustained reduction.

Market Trends

The development of oral delivery systems is significantly propelling the market forward by providing a standardized and patient-centric substitute for traditional dye spraying methods. This trend centers on the commercial release of delayed-release methylene blue tablets designed to disintegrate specifically within the colon, effectively removing the issues of uneven mucosal coating and procedural delays common with catheter-based applications. The commercial success of such pharmaceutical innovations is reflected in the strong financial results of major manufacturers; for instance, in July 2025, Cosmo Pharmaceuticals reported recurring revenues of €41.9 million for the first half of the year, a performance driven by the rising uptake of its proprietary gastrointestinal products, including these advanced delivery systems.

At the same time, the integration of chromoendoscopy with AI-assisted diagnostic platforms is setting a new clinical standard, wherein chemical agents function as essential contrast enhancers for Computer-Aided Detection (CADe) systems. This synergistic approach leverages the capacity of biochemical dyes to accentuate subtle mucosal abnormalities, which are subsequently processed by deep learning algorithms to enhance lesion detection rates and minimize operator variability. This convergence of technologies is fueling significant growth across the diagnostic industry; as noted by Fujifilm Holdings Corporation in May 2025, revenue for its Healthcare segment rose to ¥1,022.6 billion, indicating strong demand for advanced imaging ecosystems capable of supporting these hybrid diagnostic workflows.

Key Market Players

• Merck & Co., Inc.
• Enzo Life Sciences Inc
• Thermo Fisher Scientific Inc
• Cosmo Pharmaceuticals SA
• Loba Chemie Pvt Ltd
• Provepharm SAS
• Sisco Research Laboratories Pvt Ltd
• Medtronic PLC
• Boston Scientific Corp

Report Scope

In this report, the Global Chromoendoscopy Agents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Chromoendoscopy Agents Market, By Product

• Absorptive Agents
• Contrast Agents
• Reactive Agents

Chromoendoscopy Agents Market, By Application

• Colorectal
• Esophageal
• Gastric

Chromoendoscopy Agents Market, By End-Users

• Ambulatory Surgery Centers
• Diagnostic Centers
• Hospitals & Specialty Clinics
• Others

Chromoendoscopy Agents Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Chromoendoscopy Agents Market.

Available Customizations:

Global Chromoendoscopy Agents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Chromoendoscopy Agents Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Absorptive Agents, Contrast Agents, Reactive Agents)
  • 5.2.2. By Application (Colorectal, Esophageal, Gastric)
  • 5.2.3. By End-Users (Ambulatory Surgery Centers, Diagnostic Centers, Hospitals & Specialty Clinics, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Chromoendoscopy Agents Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End-Users
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Chromoendoscopy Agents Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Users
  • 6.3.2. Canada Chromoendoscopy Agents Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Users
  • 6.3.3. Mexico Chromoendoscopy Agents Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Users

7. Europe Chromoendoscopy Agents Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By End-Users
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Chromoendoscopy Agents Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Users
  • 7.3.2. France Chromoendoscopy Agents Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Users
  • 7.3.3. United Kingdom Chromoendoscopy Agents Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Users
  • 7.3.4. Italy Chromoendoscopy Agents Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Users
  • 7.3.5. Spain Chromoendoscopy Agents Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Users

8. Asia Pacific Chromoendoscopy Agents Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By End-Users
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Chromoendoscopy Agents Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Users
  • 8.3.2. India Chromoendoscopy Agents Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Users
  • 8.3.3. Japan Chromoendoscopy Agents Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Users
  • 8.3.4. South Korea Chromoendoscopy Agents Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Users
  • 8.3.5. Australia Chromoendoscopy Agents Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Users

9. Middle East & Africa Chromoendoscopy Agents Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By End-Users
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Chromoendoscopy Agents Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Users
  • 9.3.2. UAE Chromoendoscopy Agents Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Users
  • 9.3.3. South Africa Chromoendoscopy Agents Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Users

10. South America Chromoendoscopy Agents Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By End-Users
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Chromoendoscopy Agents Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Users
  • 10.3.2. Colombia Chromoendoscopy Agents Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Users
  • 10.3.3. Argentina Chromoendoscopy Agents Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Users

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Chromoendoscopy Agents Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Merck & Co., Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Enzo Life Sciences Inc
• 15.3. Thermo Fisher Scientific Inc
• 15.4. Cosmo Pharmaceuticals SA
• 15.5. Loba Chemie Pvt Ltd
• 15.6. Provepharm SAS
• 15.7. Sisco Research Laboratories Pvt Ltd
• 15.8. Medtronic PLC
• 15.9. Boston Scientific Corp

16. Strategic Recommendations

17. About Us & Disclaimer